BIOMX INC (PHGE) Fundamental Analysis & Valuation

NYSEARCA:PHGE • US09090D5095

Current stock price

2.9 USD
-0.08 (-2.68%)
At close:
2.86 USD
-0.04 (-1.38%)
After Hours:

This PHGE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PHGE Profitability Analysis

1.1 Basic Checks

  • PHGE had negative earnings in the past year.
  • In the past year PHGE has reported a negative cash flow from operations.
  • In the past 5 years PHGE always reported negative net income.
  • In the past 5 years PHGE always reported negative operating cash flow.
PHGE Yearly Net Income VS EBIT VS OCF VS FCFPHGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of PHGE (-625.96%) is worse than 94.78% of its industry peers.
Industry RankSector Rank
ROA -625.96%
ROE N/A
ROIC N/A
ROA(3y)-257.17%
ROA(5y)-176.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PHGE Yearly ROA, ROE, ROICPHGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K

1.3 Margins

  • PHGE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHGE Yearly Profit, Operating, Gross MarginsPHGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. PHGE Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, PHGE has more shares outstanding
  • The number of shares outstanding for PHGE has been increased compared to 5 years ago.
  • PHGE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PHGE Yearly Shares OutstandingPHGE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
PHGE Yearly Total Debt VS Total AssetsPHGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -69.92, we must say that PHGE is in the distress zone and has some risk of bankruptcy.
  • PHGE has a worse Altman-Z score (-69.92) than 92.84% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -69.92
ROIC/WACCN/A
WACCN/A
PHGE Yearly LT Debt VS Equity VS FCFPHGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • PHGE has a Current Ratio of 0.87. This is a bad value and indicates that PHGE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PHGE has a worse Current ratio (0.87) than 87.04% of its industry peers.
  • A Quick Ratio of 0.87 indicates that PHGE may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.87, PHGE is doing worse than 86.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
PHGE Yearly Current Assets VS Current LiabilitesPHGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PHGE Growth Analysis

3.1 Past

  • The earnings per share for PHGE have decreased strongly by -180.87% in the last year.
EPS 1Y (TTM)-180.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, PHGE will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.01% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y47.03%
EPS Next 2Y19.92%
EPS Next 3Y13.36%
EPS Next 5Y9.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHGE Yearly Revenue VS EstimatesPHGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
PHGE Yearly EPS VS EstimatesPHGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 20 -20 40 -40 60 80

More info and screens

Find the best growth stocksShow best growing peers

0

4. PHGE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PHGE. In the last year negative earnings were reported.
  • Also next year PHGE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHGE Price Earnings VS Forward Price EarningsPHGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHGE Per share dataPHGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -5 -10 -15 -20

4.3 Compensation for Growth

  • PHGE's earnings are expected to grow with 13.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.92%
EPS Next 3Y13.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHGE Dividend Analysis

5.1 Amount

  • No dividends for PHGE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHGE Fundamentals: All Metrics, Ratios and Statistics

BIOMX INC

NYSEARCA:PHGE (4/8/2026, 8:04:00 PM)

After market: 2.86 -0.04 (-1.38%)

2.9

-0.08 (-2.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-19
Earnings (Next)05-13
Inst Owners17.74%
Inst Owner Change0%
Ins Owners1.28%
Ins Owner Change0%
Market Cap4.61M
Revenue(TTM)N/A
Net Income(TTM)-36.20M
Analysts80
Price Target168.3 (5703.45%)
Short Float %7.21%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-31.3%
Min EPS beat(2)-73.75%
Max EPS beat(2)11.15%
EPS beat(4)3
Avg EPS beat(4)-2.45%
Min EPS beat(4)-73.75%
Max EPS beat(4)42.68%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-23.56
EYN/A
EPS(NY)-12.48
Fwd EYN/A
FCF(TTM)-16.6
FCFYN/A
OCF(TTM)-16.6
OCFYN/A
SpS0
BVpS-0.82
TBVpS-0.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -625.96%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-257.17%
ROA(5y)-176.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.07%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z -69.92
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2.49%
Cap/Depr(5y)31.01%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.44%
EPS Next Y47.03%
EPS Next 2Y19.92%
EPS Next 3Y13.36%
EPS Next 5Y9.01%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-18.03%
EBIT Next 3Y-7.04%
EBIT Next 5YN/A
FCF growth 1Y28.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.64%
OCF growth 3YN/A
OCF growth 5YN/A

BIOMX INC / PHGE Fundamental Analysis FAQ

What is the fundamental rating for PHGE stock?

ChartMill assigns a fundamental rating of 0 / 10 to PHGE.


What is the valuation status of BIOMX INC (PHGE) stock?

ChartMill assigns a valuation rating of 0 / 10 to BIOMX INC (PHGE). This can be considered as Overvalued.


What is the profitability of PHGE stock?

BIOMX INC (PHGE) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for PHGE stock?

The Earnings per Share (EPS) of BIOMX INC (PHGE) is expected to grow by 47.03% in the next year.